Biocon Shares Rise 3% After ₹635 Crore Block Deal: Can Biosimilars Drive the Next Growth Phase?
Biocon Shares Rise 3% After ₹635 Crore Block Deal: Can Biosimilars Drive the Next Growth Phase?
Biocon Shares Rise 3% After ₹635 Crore Block Deal: Can Biosimilars Drive the Next Growth Phase?